Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 1, 2011, Pages 37-44

  Alexander, Elizabeth L ^a   Morgan, Daniel J ^b   Kesh, Sandra ^a   Weisenberg, Scott A ^a   Zaleskas, Janice M ^c   Kaltsas, Anna ^d   Chevalier, James M ^a   Silberzweig, Jeffrey ^a   Barrón, Yolanda ^a   Mediavilla, Jose R ^e   Kreiswirth, Barry N ^e   Rhee, Kyu Y ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Colonization; Hemodialysis; Staphylococcus aureus; Vancomycin

Indexed keywords

DAPTOMYCIN; LINEZOLID; METICILLIN; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG CONCENTRATION; FEMALE; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE; NOSE SMEAR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; COHORT STUDIES; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; NEW YORK; OUTPATIENTS; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 79954988945     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.12.005     Document Type: Article

References (35)

1. Bhattacharya D., Carleton H., Tsai C.J., Baron E.J., Perdreau-Remington F. Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California. J Clin Microbiol 2007, 45:1798-1803.
2. Bommer J., Vergetis W., Andrassy K., Hingst V., Borneff M., Huber W. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J 1995, 41:127-131.
3. Cespedes C., Said-Salim B., Miller M., et al. The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 2005, 191:444-452.
4. Chow J.W., Yu V.L. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch Intern Med 1989, 149:1258-1262.
5. Clinical and Laboratory Standard Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition, M07-A8. Anonymous 2008, CLSI, Wayne, PA.
6. del Rio A., Cervera C., Moreno A., Moreillon P., Miro J.M. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis 2009, 48(Suppl 4):S246-S253.
7. DeLeo F.R., Chambers H.F. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 2009, 119:2464-2474.
8. Diep B.A., Stone G.G., Basuino L., et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008, 197:1523-1530.
9. Doebbeling B.N., Reagan D.R., Pfaller M.A., Houston A.K., Hollis R.J., Wenzel R.P. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994, 154:1505-1508.
10. Elie-Turenne M.C., Fernandes H., Mediavilla J.R., et al. Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infect Control Hosp Epidemiol 2010, 31:574-580.
11. Gould I.M. MRSA bacteraemia. Int J Antimicrob Agents 2007, 30(Suppl 1):S66-S70.
12. Harris A.D., Furuno J.P., Roghmann M.C., et al. Targeted MRSA surveillance and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010.
13. Hidron A.I., Kourbatova E.V., Halvosa J.S., et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005, 41:159-166.
14. Hu L., Umeda A., Kondo S., Amako K. Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis. J Med Microbiol 1995, 42:127-132.
15. Jernigan J.A., Pullen A.L., Flowers L., Bell M., Jarvis W.R. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003, 24:409-414.
16. Johnson L.B., Jose J., Yousif F., Pawlak J., Saravolatz L.D. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 2009, 30:4-8.
17. Klevens R.M., Morrison M.A.N.J., Petit S., et al. nvasive methicillin-resistant Staphylococcus aureus infections in the United States. jama the journal of the american medical association 2007, 298:1763.
18. Kluytmans J.A., Manders M.J., van Bommel E., Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996, 17:793-797.
19. Koeth L.M., Thorne G.M. Daptomycin in vitro susceptibility methodology: a review of methods, including determination of calcium in testing media. Clin Microbiol News 2010, 32:161.
20. Lu P.L., Chin L.C., Peng C.F., et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005, 43:132-139.
21. Mathema B., Mediavilla J., Kreiswirth B.N. Sequence analysis of the variable number tandem repeat in Staphylococcus aureus protein A gene: spa typing. Methods Mol Biol 2008, 431:285-305.
22. Mermel L.A., Eells S.J., Acharya M.K., et al. Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter study. Infect Control Hosp Epidemiol 2010, 31:592-597.
23. Miller M., Cespedes C., Bhat M., Vavagiakis P., Klein R.S., Lowy F.D. Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin Infect Dis 2007, 45:343-346.
24. Moise P.A., Smyth D.S., El-Fawal N., et al. Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2008, 61:85-90.
25. Moise P.A., Sakoulas G., Forrest A., Schentag J.J. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2007, 51:2582-2586.
26. Roberts R.B., de Lencastre A., Eisner W., et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group. J Infect Dis 1998, 178:164-171.
27. Rybak M.J., Leonard S.N., Rossi K.L., Cheung C.M., Sader H.S., Jones R.N. Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J Clin Microbiol 2008, 46:2950-2954.
28. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering R.C., Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004, 42:2398-2402.
29. Shet A., Mathema B., Mediavilla J.R., et al. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. J Infect Dis 2009, 200:88-93.
30. Sinsimer D., Leekha S., Park S., et al. Use of a multiplex molecular beacon platform for rapid detection of methicillin and vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2005, 43:4585-4591.
31. Strommenger B., Kettlitz C., Weniger T., Harmsen D., Friedrich A.W., Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol 2006, 44:2533-2540.
32. Van Belkum A., Riewarts Eriksen N.H., Sijmons M., et al. Coagulase and protein A polymorphisms do not contribute to persistence of nasal colonisation by Staphylococcus aureus. J Med Microbiol 1997, 46:222-232.
33. von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001, 344:11-16.
34. Wagenvoort J.H., De Brauwer E.I., Sijstermans M.L., Toenbreker H.M. Risk of re-introduction of methicillin-resistant Staphylococcus aureus into the hospital by intrafamilial spread from and to healthcare workers. J Hosp Infect 2005, 59:67-68.
35. Yusof A., Engelhardt A., Karlsson A., et al. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol 2008, 46:3042-3047.